Are 18 fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

By Maisey N.R.   Hill M.E.   Webb A.   Cunningham D.   Flux G.D.   Padhani A.   Ott R.J.   Norman A.   Bishop L.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 200-206

Elsevier

Access to resources Recommend Favorite

Positron Emission Tomography with 18 F-Fluorodeoxyglucose of Uterine Sarcoma: A Comparison with Magnetic Resonance Imaging and Power Doppler Imaging

By Umesaki N.   Tanaka T.   Miyama M.   Kawamura N.   Ogita S.   Kawabe J.   Okamura T.   Koyama K.   Ochi H.  

Gynecologic Oncology, Vol. 80, Iss. 3, 2001-03 ,pp. : 372-377

Elsevier

Access to resources Recommend Favorite

Improved quality of computed tomography substitute derived from magnetic resonance (MR) data by incorporation of spatial information – potential application for MR-only radiotherapy and attenuation correction in positron emission tomography

By Johansson Adam   Garpebring Anders   Karlsson Mikael   Asklund Thomas   Nyholm Tufve  

Acta Oncologica, Vol. 52, Iss. 7, 2013-10 ,pp. : 1369-1373

Informa Healthcare

Access to resources Recommend Favorite

Histologic correlation with magnetic resonance imaging for benign and malignant lipomatous masses

By Rougraff Bruce T.   Durbin Mark   Lawerence Jackie   Buckwalter Kenneth  

Sarcoma, Vol. 1, Iss. 3-4, 1997-12 ,pp. : 175-179

Informa Healthcare

Access to resources Recommend Favorite

Positron Emission Tomography/Computed Tomography Imaging for the Detection of Recurrent Ovarian and Fallopian Tube Carcinoma: A Retrospective Review

By Makhija S.   Howden N.   Edwards R.   Kelley J.   Townsend D.W.   Meltzer C.C.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite